Robots and AI are running experiments around the clock, from battery chemistry to cancer therapies. But can they be trusted ...

Stanford report reveals why Utah’s flagship university is a top destination for entrepreneurs.

Anthropic is calling for joint efforts to slow the development of AI, using arms control agreements as a model. But that's a ...

Google DeepMind's new report maps four pathways from AGI to artificial superintelligence. Here's how scaling, paradigm shifts ...

As enterprises race to deploy AI copilots and autonomous agents, finance leaders are finding the hardest part isn't buying AI ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

As the nation marks 250 years since the signing of the Declaration of Independence, the Smithsonian invites educators to ...

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

AbCellera has an AI-driven antibody discovery platform, $650M liquidity, and an upcoming Phase 2 catalyst. Click here to read ...